Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.

Rauert-Wunderlich H, Mottok A, Scott DW, Rimsza LM, Ott G, Klapper W, Unterhalt M, Kluin-Nelemans HC, Hermine O, Hartmann S, Thorns C, Rymkiewicz G, Holte H, Dreyling M, Hoster E, Rosenwald A.

Br J Haematol. 2018 Aug 10. doi: 10.1111/bjh.15519. [Epub ahead of print]

PMID:
30095158
2.

Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units.

de Vries VA, Müller MCA, Sesmu Arbous M, Biemond BJ, Blijlevens NMA, Kusadasi N, Choi GCW, Vlaar APJ, van Westerloo DJ, Kluin-Nelemans HC, van den Bergh WM; HEMA-ICU Study Group.

Br J Haematol. 2018 Apr;181(1):68-76. doi: 10.1111/bjh.15140. Epub 2018 Feb 22.

PMID:
29468848
3.

Relapse in stage I(E) diffuse large B-cell lymphoma.

Nijland M, Boslooper K, van Imhoff G, Kibbelaar R, Joosten P, Storm H, van Roon EN, Diepstra A, Kluin-Nelemans HC, Hoogendoorn M.

Hematol Oncol. 2018 Apr;36(2):416-421. doi: 10.1002/hon.2487. Epub 2017 Oct 30.

4.

Midostaurin: a magic bullet that blocks mast cell expansion and activation.

Valent P, Akin C, Hartmann K, George TI, Sotlar K, Peter B, Gleixner KV, Blatt K, Sperr WR, Manley PW, Hermine O, Kluin-Nelemans HC, Arock M, Horny HP, Reiter A, Gotlib J.

Ann Oncol. 2017 Oct 1;28(10):2367-2376. doi: 10.1093/annonc/mdx290. Review.

PMID:
28945834
5.

Management around invasive procedures in mastocytosis: An update.

Hermans MAW, Arends NJT, Gerth van Wijk R, van Hagen PM, Kluin-Nelemans HC, Oude Elberink HNG, Pasmans SGMA, van Daele PLA.

Ann Allergy Asthma Immunol. 2017 Oct;119(4):304-309. doi: 10.1016/j.anai.2017.07.022. Epub 2017 Aug 31. Review.

PMID:
28866309
6.

MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.

Aukema SM, van Pel R, Nagel I, Bens S, Siebert R, Rosati S, van den Berg E, Bosga-Bouwer AG, Kibbelaar RE, Hoogendoorn M, van Imhoff GW, Kluin-Nelemans HC, Kluin PM, Nijland M.

Histopathology. 2017 Dec;71(6):960-971. doi: 10.1111/his.13316. Epub 2017 Oct 17.

PMID:
28730642
7.

No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status.

Boslooper K, Hoogendoorn M, van Roon EN, Kibbelaar RE, Storm H, Hovenga S, Woolthuis G, van Rees BP, Klijs B, Veeger NJGM, Kluin-Nelemans HC, de Bock GH.

Cancer Epidemiol. 2017 Jun;48:110-116. doi: 10.1016/j.canep.2017.04.009. Epub 2017 Apr 29.

8.

Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma.

Nijland M, Jansen A, Doorduijn JK, Enting RH, Bromberg JEC, Kluin-Nelemans HC.

Leuk Lymphoma. 2017 Sep;58(9):1-6. doi: 10.1080/10428194.2017.1285026. Epub 2017 Feb 6.

PMID:
28278731
9.

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD.

Cancer Res. 2017 Mar 15;77(6):1261-1270. doi: 10.1158/0008-5472.CAN-16-2234. Epub 2017 Mar 2. Review.

10.

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.

Ustun C, Arock M, Kluin-Nelemans HC, Reiter A, Sperr WR, George T, Horny HP, Hartmann K, Sotlar K, Damaj G, Hermine O, Verstovsek S, Metcalfe DD, Gotlib J, Akin C, Valent P.

Haematologica. 2016 Oct;101(10):1133-1143. Review.

11.

Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists.

Kooistra HA, Calf AH, Piersma-Wichers M, Kluin-Nelemans HC, Izaks GJ, Veeger NJ, Meijer K.

JAMA Intern Med. 2016 Aug 1;176(8):1176-83. doi: 10.1001/jamainternmed.2016.3057.

PMID:
27379731
12.

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

Gotlib J, Kluin-Nelemans HC, George TI, Akin C, Sotlar K, Hermine O, Awan FT, Hexner E, Mauro MJ, Sternberg DW, Villeneuve M, Huntsman Labed A, Stanek EJ, Hartmann K, Horny HP, Valent P, Reiter A.

N Engl J Med. 2016 Jun 30;374(26):2530-41. doi: 10.1056/NEJMoa1513098.

13.

Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients.

Kooistra HA, Piersma-Wichers M, Kluin-Nelemans HC, Veeger NJ, Meijer K.

Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):388-94. doi: 10.1161/CIRCOUTCOMES.115.002612. Epub 2016 Jun 21.

PMID:
27329860
14.

The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.

van Vlijmen EF, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Kluin-Nelemans HC, Meijer K.

J Thromb Haemost. 2016 Sep;14(9):1741-8. doi: 10.1111/jth.13393. Epub 2016 Aug 11.

15.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R, Kluin-Nelemans HC, Verstovsek S, Gajewski J, Perales MA, George T, Shore T, Sperr W, Saber W, Kota V, Yavuz AS, Pullarkat V, Rogosheske J, Hogan W, Van Besien K, Hagglund H, Damaj G, Arock M, Horny HP, Metcalfe DD, Deeg HJ, Devine S, Weisdorf D, Akin C, Valent P.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1348-1356. doi: 10.1016/j.bbmt.2016.04.018. Epub 2016 Apr 27. No abstract available.

16.

Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600)E Lesion.

Weston-Bell NJ, Tapper W, Gibson J, Bryant D, Moreno Y, John M, Ennis S, Kluin-Nelemans HC, Collins AR, Sahota SS.

PLoS One. 2016 Feb 12;11(2):e0149162. doi: 10.1371/journal.pone.0149162. eCollection 2016.

17.

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.

Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MA, Ramadan S, Meulemans B, Henry-Amar M, Aleman BM, Raemaekers J, Meijnders P, Moser EC, Kluin-Nelemans HC, Feugier P, Casasnovas O, Fortpied C, Specht L; European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group.

Lancet Haematol. 2015 Nov;2(11):e492-502. doi: 10.1016/S2352-3026(15)00153-2. Epub 2015 Oct 22.

PMID:
26686259
18.

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JNG, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hägglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P.

J Allergy Clin Immunol. 2016 Jan;137(1):35-45. doi: 10.1016/j.jaci.2015.08.034. Epub 2015 Oct 21. Review.

PMID:
26476479
19.

Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.

van Vlijmen EF, Mäkelburg AB, Knol HM, Tichelaar VI, Kluin-Nelemans HC, Veeger NJ, Meijer K.

Br J Haematol. 2016 Feb;172(4):636-8. doi: 10.1111/bjh.13534. Epub 2015 Jun 24. No abstract available.

PMID:
26105591
20.

Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?

Kluin PM, Langerak AW, Beverdam-Vincent J, Geurts-Giele WR, Visser L, Rutgers B, Schuuring E, Van Baarlen J, Lam KH, Seldenrijk K, Kibbelaar RE, de Wit P, Diepstra A, Rosati S, van Noesel MM, Zwaan CM, Hunting JC, Hoogendoorn M, van der Gaag EJ, van Esser JW, de Bont E, Kluin-Nelemans HC, Winter RH, Lo Ten Foe JR, van der Zanden AG.

J Pathol. 2015 Jul;236(3):302-14. doi: 10.1002/path.4524. Epub 2015 Apr 8.

PMID:
25722108
21.

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Arock M, Sotlar K, Akin C, Broesby-Olsen S, Hoermann G, Escribano L, Kristensen TK, Kluin-Nelemans HC, Hermine O, Dubreuil P, Sperr WR, Hartmann K, Gotlib J, Cross NC, Haferlach T, Garcia-Montero A, Orfao A, Schwaab J, Triggiani M, Horny HP, Metcalfe DD, Reiter A, Valent P.

Leukemia. 2015 Jun;29(6):1223-32. doi: 10.1038/leu.2015.24. Epub 2015 Feb 4. Review.

22.

Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.

Kooistra HA, Veeger NJ, Khorsand N, Kluin-Nelemans HC, Meijer K, Piersma-Wichers M.

Thromb Haemost. 2015 Apr;113(4):881-90. doi: 10.1160/TH14-06-0537. Epub 2014 Dec 18. Erratum in: Thromb Haemost. 2015 Aug 31;114(3):656.

PMID:
25518854
23.

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii83-92. doi: 10.1093/annonc/mdu264. No abstract available.

24.

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Valent P, Escribano L, Broesby-Olsen S, Hartmann K, Grattan C, Brockow K, Niedoszytko M, Nedoszytko B, Oude Elberink JN, Kristensen T, Butterfield JH, Triggiani M, Alvarez-Twose I, Reiter A, Sperr WR, Sotlar K, Yavuz S, Kluin-Nelemans HC, Hermine O, Radia D, van Doormaal JJ, Gotlib J, Orfao A, Siebenhaar F, Schwartz LB, Castells M, Maurer M, Horny HP, Akin C, Metcalfe DD, Arock M; European Competence Network on Mastocytosis.

Allergy. 2014 Oct;69(10):1267-74. doi: 10.1111/all.12436. Epub 2014 May 19.

PMID:
24836395
25.

Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.

Wieringa A, Boslooper K, Hoogendoorn M, Joosten P, Beerden T, Storm H, Kibbelaar RE, Veldhuis GJ, van Kamp H, van Rees B, Kluin-Nelemans HC, Veeger NJ, van Roon EN.

Br J Haematol. 2014 May;165(4):489-96. doi: 10.1111/bjh.12765. Epub 2014 Feb 7.

PMID:
24754632
26.

Splenectomy and second malignancies in patients with Hodgkin lymphoma.

Kooistra HA, Kluin-Nelemans HC, van Imhoff GW, van Dijk BA, de Bock GH, van der Kaaij MA.

Leuk Lymphoma. 2015 Jan;56(1):230-1. doi: 10.3109/10428194.2014.910658. Epub 2014 May 12. No abstract available.

PMID:
24707939
27.

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M, Stilgenbauer S, Thieblemont C, Hallek M, Forstpointner R, Pott C, Ribrag V, Doorduijn J, Hiddemann W, Dreyling MH, Unterhalt M.

J Clin Oncol. 2014 May 1;32(13):1338-46. doi: 10.1200/JCO.2013.52.2466. Epub 2014 Mar 31.

PMID:
24687837
28.

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Valent P, Sotlar K, Sperr WR, Escribano L, Yavuz S, Reiter A, George TI, Kluin-Nelemans HC, Hermine O, Butterfield JH, Hägglund H, Ustun C, Hornick JL, Triggiani M, Radia D, Akin C, Hartmann K, Gotlib J, Schwartz LB, Verstovsek S, Orfao A, Metcalfe DD, Arock M, Horny HP.

Ann Oncol. 2014 Sep;25(9):1691-700. doi: 10.1093/annonc/mdu047. Epub 2014 Mar 27. Review.

29.

Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.

Weston-Bell NJ, Forconi F, Kluin-Nelemans HC, Sahota SS.

PLoS One. 2014 Jan 30;9(1):e86556. doi: 10.1371/journal.pone.0086556. eCollection 2014.

30.

Incidence of hypersensitivity skin reactions in patients on full-dose low-molecular-weight heparins during pregnancy.

Schultinge L, Knol HM, Kluin-Nelemans HC, Erwich JJ, Meijer K.

Neth J Med. 2013 Dec;71(10):518-22.

31.

Pain and anxiety during bone marrow biopsy.

Tanasale B, Kits J, Kluin PM, Trip A, Kluin-Nelemans HC.

Pain Manag Nurs. 2013 Dec;14(4):310-317. doi: 10.1016/j.pmn.2011.06.007. Epub 2011 Oct 17.

PMID:
24315253
32.

Management of mantle cell lymphoma in the elderly patient.

Doorduijn JK, Kluin-Nelemans HC.

Clin Interv Aging. 2013;8:1229-36. doi: 10.2147/CIA.S35082. Epub 2013 Sep 16. Review.

33.

Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome.

Boslooper K, Kibbelaar R, Storm H, Veeger NJ, Hovenga S, Woolthuis G, van Rees B, de Graaf E, van Roon E, Kluin-Nelemans HC, Joosten P, Hoogendoorn M.

Leuk Lymphoma. 2014 Mar;55(3):526-32. doi: 10.3109/10428194.2013.810737. Epub 2013 Jul 29.

PMID:
23734653
34.

The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities.

Knol HM, Mulder AB, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, Meijer K.

Am J Obstet Gynecol. 2013 Sep;209(3):202.e1-7. doi: 10.1016/j.ajog.2013.05.059. Epub 2013 May 30.

PMID:
23727521
35.

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network.

Cheah CY, George A, Giné E, Chiappella A, Kluin-Nelemans HC, Jurczak W, Krawczyk K, Mocikova H, Klener P, Salek D, Walewski J, Szymczyk M, Smolej L, Auer RL, Ritchie DS, Arcaini L, Williams ME, Dreyling M, Seymour JF; European Mantle Cell Lymphoma Network.

Ann Oncol. 2013 Aug;24(8):2119-23. doi: 10.1093/annonc/mdt139. Epub 2013 Apr 24.

PMID:
23616279
36.

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.

Valent P, Arock M, Bonadonna P, Brockow K, Broesby-Olsen S, Escribano L, Gleixner KV, Grattan C, Hadzijusufovic E, Hägglund H, Hermine O, Horny HP, Kluin-Nelemans HC, Maurer M, Niedoszytko M, Nedoszytko B, Nilsson G, Oude-Elberink HN, Orfao A, Radia D, Reiter A, Siebenhaar F, Sotlar K, Sperr WR, Triggiani M, VanDoormaal JJ, Várkonyi J, Yavuz S, Hartmann K.

Wien Klin Wochenschr. 2012 Dec;124(23-24):807-14. doi: 10.1007/s00508-012-0293-z. Epub 2012 Nov 20. Review.

PMID:
23179435
37.

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).

Ghielmini M, Vitolo U, Kimby E, Montoto S, Walewski J, Pfreundschuh M, Federico M, Hoskin P, McNamara C, Caligaris-Cappio F, Stilgenbauer S, Marcus R, Trneny M, Dreger P, Montserrat E, Dreyling M; Panel Members of the 1st ESMO Consensus Conference on Malignant Lymphoma.

Ann Oncol. 2013 Mar;24(3):561-76. doi: 10.1093/annonc/mds517. Epub 2012 Nov 21.

PMID:
23175624
38.

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.

Dreyling M, Kluin-Nelemans HC, Beà S, Klapper W, Vogt N, Delfau-Larue MH, Hutter G, Cheah C, Chiappella A, Cortelazzo S, Pott C, Hess G, Visco C, Vitolo U, Klener P, Aurer I, Unterhalt M, Ribrag V, Hoster E, Hermine O; European MCL Network.

Leuk Lymphoma. 2013 Apr;54(4):699-707. doi: 10.3109/10428194.2012.733882. Epub 2012 Nov 21. Review.

PMID:
23020649
39.

Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WG, Bologna S, Roesink JM, Ong F, André MP, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC.

J Clin Oncol. 2012 Nov 1;30(31):3854-63. doi: 10.1200/JCO.2011.40.8906. Epub 2012 Sep 24.

PMID:
23008303
40.

Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study.

van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, Muntinghe FL, Dullaart RP, Kluin-Nelemans HC, Veeger NJ, Meijer K.

Thromb Haemost. 2012 Nov;108(5):923-9. doi: 10.1160/TH12-06-0426. Epub 2012 Sep 5.

PMID:
22955992
41.

Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study.

van Schouwenburg IM, Gansevoort RT, Mahmoodi BK, Visser MM, Kluin-Nelemans HC, Lijfering WM, Veeger NJ.

Br J Haematol. 2012 Oct;159(2):216-22. doi: 10.1111/bjh.12005. Epub 2012 Aug 24.

PMID:
22924556
42.

Treatment of older patients with mantle-cell lymphoma.

Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Trneny M, Geisler CH, Stilgenbauer S, Thieblemont C, Vehling-Kaiser U, Doorduijn JK, Coiffier B, Forstpointner R, Tilly H, Kanz L, Feugier P, Szymczyk M, Hallek M, Kremers S, Lepeu G, Sanhes L, Zijlstra JM, Bouabdallah R, Lugtenburg PJ, Macro M, Pfreundschuh M, Procházka V, Di Raimondo F, Ribrag V, Uppenkamp M, André M, Klapper W, Hiddemann W, Unterhalt M, Dreyling MH.

N Engl J Med. 2012 Aug 9;367(6):520-31. doi: 10.1056/NEJMoa1200920.

43.

Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.

Weston-Bell NJ, Hendriks D, Sugiyarto G, Bos NA, Kluin-Nelemans HC, Forconi F, Sahota SS.

Leukemia. 2013 Jan;27(1):241-5. doi: 10.1038/leu.2012.163. Epub 2012 Jun 18. No abstract available.

PMID:
22705994
44.

The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantations.

Lisman T, Pittau G, Leite FJ, De Boer MT, Meijer K, Kluin-Nelemans HC, Huls G, Te Boome LC, Kuball J, Nowak G, Fan ST, Azoulay D, Porte RJ.

J Thromb Haemost. 2012 Aug;10(8):1624-30. doi: 10.1111/j.1538-7836.2012.04800.x.

45.

The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.

Knol HM, Schultinge L, Veeger NJ, Kluin-Nelemans HC, Erwich JJ, Meijer K.

Thromb Res. 2012 Sep;130(3):334-8. doi: 10.1016/j.thromres.2012.03.007. Epub 2012 Apr 3.

PMID:
22475315
46.

Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study.

Van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Bakker SJ, Kluin-Nelemans HC, Meijer K, Gansevoort RT.

J Thromb Haemost. 2012 Jun;10(6):1012-8. doi: 10.1111/j.1538-7836.2012.04707.x.

47.

PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels.

Mulder R, ten Kate MK, Kluin-Nelemans HC, Mulder AB.

Thromb Haemost. 2012 Mar;107(3):594-6. doi: 10.1160/TH11-08-0549. Epub 2012 Jan 25. No abstract available.

PMID:
22273984
48.

Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study.

van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Kluin-Nelemans HC, Gansevoort RT, Meijer K.

Br J Haematol. 2012 Mar;156(5):667-71. doi: 10.1111/j.1365-2141.2011.09018.x. Epub 2012 Jan 11.

PMID:
22233096
49.

High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.

van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ.

Allergy. 2012 Mar;67(3):431-8. doi: 10.1111/j.1398-9995.2011.02780.x. Epub 2012 Jan 9.

PMID:
22229787
50.

Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC.

J Clin Oncol. 2012 Jan 20;30(3):291-9. doi: 10.1200/JCO.2011.37.1989. Epub 2011 Dec 19.

PMID:
22184372

Supplemental Content

Loading ...
Support Center